Literature DB >> 24184653

Select 3',5'-cyclic nucleotide phosphodiesterases exhibit altered expression in the aged rodent brain.

Michy P Kelly1, Wendy Adamowicz2, Susan Bove3, Alexander J Hartman4, Abigail Mariga5, Geetanjali Pathak4, Veronica Reinhart6, Alison Romegialli7, Robin J Kleiman8.   

Abstract

3',5'-cyclic nucleotide phosphodiesterases (PDEs) are the only known enzymes to compartmentalize cAMP and cGMP, yet little is known about how PDEs are dynamically regulated across the lifespan. We mapped mRNA expression of all 21 PDE isoforms in the adult rat and mouse central nervous system (CNS) using quantitative polymerase chain reaction (qPCR) and in situ hybridization to assess conservation across species. We also compared PDE mRNA and protein in the brains of old (26 months) versus young (5 months) Sprague-Dawley rats, with select experiments replicated in old (9 months) versus young (2 months) BALB/cJ mice. We show that each PDE isoform exhibits a unique expression pattern across the brain that is highly conserved between rats, mice, and humans. PDE1B, PDE1C, PDE2A, PDE4A, PDE4D, PDE5A, PDE7A, PDE8A, PDE8B, PDE10A, and PDE11A showed an age-related increase or decrease in mRNA expression in at least 1 of the 4 brain regions examined (hippocampus, cortex, striatum, and cerebellum). In contrast, mRNA expression of PDE1A, PDE3A, PDE3B, PDE4B, PDE7A, PDE7B, and PDE9A did not change with age. Age-related increases in PDE11A4, PDE8A3, PDE8A4/5, and PDE1C1 protein expression were confirmed in hippocampus of old versus young rodents, as were age-related increases in PDE8A3 protein expression in the striatum. Age-related changes in PDE expression appear to have functional consequences as, relative to young rats, the hippocampi of old rats demonstrated strikingly decreased phosphorylation of GluR1, CaMKIIα, and CaMKIIβ, decreased expression of the transmembrane AMPA regulatory proteins γ2 (a.k.a. stargazin) and γ8, and increased trimethylation of H3K27. Interestingly, expression of PDE11A4, PDE8A4/5, PDE8A3, and PDE1C1 correlate with these functional endpoints in young but not old rats, suggesting that aging is not only associated with a change in PDE expression but also a change in PDE compartmentalization.
© 2013.

Entities:  

Keywords:  Alzheimer's disease; Model; Neuron; PDE11; PDE8; Tissue distribution

Mesh:

Substances:

Year:  2013        PMID: 24184653     DOI: 10.1016/j.cellsig.2013.10.007

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  42 in total

1.  Leptin receptor expressing neurons express phosphodiesterase-3B (PDE3B) and leptin induces STAT3 activation in PDE3B neurons in the mouse hypothalamus.

Authors:  Maitrayee Sahu; Abhiram Sahu
Journal:  Peptides       Date:  2015-08-20       Impact factor: 3.750

2.  Cross-regulation of Phosphodiesterase 1 and Phosphodiesterase 2 Activities Controls Dopamine-mediated Striatal α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptor Trafficking.

Authors:  Roy S Song; Rosa Tolentino; Eric A Sobie; Susana R Neves-Zaph
Journal:  J Biol Chem       Date:  2016-09-07       Impact factor: 5.157

Review 3.  Cyclic nucleotide signaling changes associated with normal aging and age-related diseases of the brain.

Authors:  Michy P Kelly
Journal:  Cell Signal       Date:  2017-11-23       Impact factor: 4.315

Review 4.  A Role for Phosphodiesterase 11A (PDE11A) in the Formation of Social Memories and the Stabilization of Mood.

Authors:  Michy P Kelly
Journal:  Adv Neurobiol       Date:  2017

5.  Detection of phasic dopamine by D1 and D2 striatal medium spiny neurons.

Authors:  Cedric Yapo; Anu G Nair; Lorna Clement; Liliana R Castro; Jeanette Hellgren Kotaleski; Pierre Vincent
Journal:  J Physiol       Date:  2017-09-02       Impact factor: 5.182

6.  Phosphodiesterase-1b deletion confers depression-like behavioral resistance separate from stress-related effects in mice.

Authors:  J R Hufgard; M T Williams; C V Vorhees
Journal:  Genes Brain Behav       Date:  2017-06-07       Impact factor: 3.449

7.  Phosphodiesterase-1b (Pde1b) knockout mice are resistant to forced swim and tail suspension induced immobility and show upregulation of Pde10a.

Authors:  Jillian R Hufgard; Michael T Williams; Matthew R Skelton; Olivera Grubisha; Filipa M Ferreira; Helen Sanger; Mary E Wright; Tracy M Reed-Kessler; Kurt Rasmussen; Ronald S Duman; Charles V Vorhees
Journal:  Psychopharmacology (Berl)       Date:  2017-03-23       Impact factor: 4.530

8.  The TMEM106B FTLD-protective variant, rs1990621, is also associated with increased neuronal proportion.

Authors:  Zeran Li; Fabiana H G Farias; Umber Dube; Jorge L Del-Aguila; Kathie A Mihindukulasuriya; Maria Victoria Fernandez; Laura Ibanez; John P Budde; Fengxian Wang; Allison M Lake; Yuetiva Deming; James Perez; Chengran Yang; Jorge A Bahena; Wei Qin; Joseph L Bradley; Richard Davenport; Kristy Bergmann; John C Morris; Richard J Perrin; Bruno A Benitez; Joseph D Dougherty; Oscar Harari; Carlos Cruchaga
Journal:  Acta Neuropathol       Date:  2019-08-27       Impact factor: 17.088

9.  Identification of new PDE9A isoforms and how their expression and subcellular compartmentalization in the brain change across the life span.

Authors:  Neema S Patel; Jennifer Klett; Katy Pilarzyk; Dong Ik Lee; David Kass; Frank S Menniti; Michy P Kelly
Journal:  Neurobiol Aging       Date:  2018-02-05       Impact factor: 4.673

10.  In vitro and in vivo characterisation of Lu AF64280, a novel, brain penetrant phosphodiesterase (PDE) 2A inhibitor: potential relevance to cognitive deficits in schizophrenia.

Authors:  John P Redrobe; Morten Jørgensen; Claus T Christoffersen; Liliana P Montezinho; Jesper F Bastlund; Martin Carnerup; Christoffer Bundgaard; Linda Lerdrup; Niels Plath
Journal:  Psychopharmacology (Berl)       Date:  2014-03-01       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.